Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opiant Pharmaceuticals Inc (OTCQB:OPNT)

23.05
Delayed Data
As of Aug 18
 -0.95 / -3.96%
Today’s Change
5.00
Today|||52-Week Range
25.38
+310.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues312.5K1.1M13.5M18.1K
 
 
 
 
 
Depreciation And Amortization1.2K1.3K1.3K1.3K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses1.5M1.7M2.9M3.2M
 
 
 
 
 
Research And Development--441.8K344.8K1.1M
 
 
 
 
Total Operating Expenses1.5M1.7M2.9M3.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M-579.0K10.6M-3.2M
 
 
 
 
 
Interest Expense On Debt571.002.2K0.000.00
 
 
 
Other Expenses-39.0K-19.4K11.0K25.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.1M-600.6K10.6M-3.1M
 
 
 
 
 
Net Income-1.1M-600.6K10.6M-3.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.0M2.0M2.0M2.0M
 
 
 
 
 
Shares To Calculate EPS Diluted2.0M2.0M2.2M2.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.52-$0.30$4.91-$1.55
 
 
 
 
 
EPS Diluted-$0.55-$0.30$4.91-$1.55